ASH 2021 Conference Coverage on VuMedi

 

ASH 2021 Conference Coverage on VuMedi
E

ASH 2021 Highlights on Treatment Options for AL Amyloidosis Patients Ineligible for Autologous Transplantation

By ASH 2021 Conference Coverage on VuMedi FEATURING Efstathios Kastritis
By ASH 2021 Conference Coverage on VuMedi FEATURING Efstathios Kastritis
110 views
December 20, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

15:11
Incyte

The Importance of Intervention at the First Signs of Initial Systemi…

Feat. P. Chaudhary

Featured Video

12:58
Incyte

Spleen Volume Reduction and Long-Term Survival in Myelofibrosis: Whe…

Feat. R. Mesa
Myeloma
05:27

ASH 2021 Sustained Improvement in HRQoL in Transplant-Ineligible Pat…

ASH 2021 Conference Coverage on VuMedi

A. Perrot

86 views
10:50

ASH 2021 Updates on the Efficacy and Safety of Cilta-Cel in R/R MM: …

ASH 2021 Conference Coverage on VuMedi

A. Jakubowiak

188 views
13:38

2022 Updates on CAR T-Cell Therapy for Myeloma

ASH 2021 Conference Coverage on VuMedi

L. Anderson

44 views
05:57

ASH 2021 Update on the Impact of EPd on HRQoL for Patients With R/R …

ASH 2021 Conference Coverage on VuMedi

K. Weisel

296 views
05:25

ASH 2021 on the Efficacy and Safety of Cilta-cel in Len-Refractory P…

ASH 2021 Conference Coverage on VuMedi

Y. C. Cohen

62 views
08:31

ASH 2021 Updated Results From the Phase I CRB-402 Study of the BCMA-…

ASH 2021 Conference Coverage on VuMedi

N. S. Raje

15 views
16:29

ASH 2021 Review of MRD in MM: Why, When, Where, and How?

ASH 2021 Conference Coverage on VuMedi

N. S. Raje

185 views
13:12

ASH 2021: Addressing Current Questions and Controversies in the Mana…

ASH 2021 Conference Coverage on VuMedi

M. Gertz

392 views
07:41

ASH 2021 Update on Cilta-Cel for Triple-Class Exposed MM: Adjusted C…

ASH 2021 Conference Coverage on VuMedi

M. Mateos

126 views
04:34

ASH 2021 on the Safety, Tolerability, PK/PD, and Preliminary Efficac…

ASH 2021 Conference Coverage on VuMedi

N. Shah

66 views
04:19

ASH 2021: Risk of Infections With BCMA-Directed Immunotherapy in Mul…

ASH 2021 Conference Coverage on VuMedi

M. Mohan

87 views
07:00

ASH 2021 Updates on Outcomes in HR-MM Treated With Daratumumab

ASH 2021 Conference Coverage on VuMedi

F. van Rhee

117 views
13:23

ASH 2021 Highlights on Treatment Options for AL Amyloidosis Patients…

ASH 2021 Conference Coverage on VuMedi

E. Kastritis

110 views
09:07

ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negati…

ASH 2021 Conference Coverage on VuMedi

E. Boyle

166 views
06:08

ASH 2021 Update on the Efficacy and Safety of Ruxolitinib and Steroi…

ASH 2021 Conference Coverage on VuMedi

J. Berenson

124 views
11:03

ASH 2021 Lecture on Clinical Outcomes of R/R MM Patients Following T…

ASH 2021 Conference Coverage on VuMedi

T. Mouhieddine

74 views